Gynecological cancers remain a major threat to women's health, with traditional therapies often having limited effect and ...

MONTREAL, Nov. 13, 2025 /CNW/ - Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep (R) (belantamab mafodotin) -- a critical new ...

The Doodle shows how the parabola changes with different numbers, making learning math fun and interactive for students.,, ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

IntoCell Inc. (KOSDAQ: 287840), a biotechnology company developing next-generation payload and linker technologies for antibody–drug conjugates (ADCs), and Xcellon Biologics, a U.S.-based contract ...

Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for ...

MONTREAL, Nov. 13, 2025 /CNW/ – Myeloma Canada welcomes the Canadian Drug Agency’s (CDA) two positive recommendations for the ...

Odyssey Math Tuition launches JC 1 H2 Math online tuition elearning course in Singapore, featuring a proprietary MOE-aligned ...

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.

Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its ...